NCT05967091View on ClinicalTrials.gov

Ryme Medical TLD Pilot Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

May 22, 2025

Study Completion Date

May 31, 2026

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DEVICE

Targeted Lung Denervation

Targeted Lung Denervation (TLD) is a bronchoscopically guided, minimally invasive procedure using the Ryme Medical Lung Denervation System

Trial Locations (7)

Unknown

Melbourne Health - The Royal Melbourne Hospital, Melbourne

Macquarie University, Sydney

Karl Landsteiner Institute for Lung Research, Vienna

Rigshospitalet, Copenhagen

Healthycore, Tbilisi

University of Groningen Medical Center, Groningen

Royal Brompton, London

All Listed Sponsors
lead

Ryme Medical, Inc.

INDUSTRY